Search

everythinglearnresearchcommunity

for

Search:↓

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Balding and low testosterone increase risk of urinary stones.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Targeting colon cancer stem cells might lead to better treatment results.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.